| Product Code: ETC6741743 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Drug Safety Solutions and Pharmacovigilance Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, 2021 & 2031F |
3.3 China Drug Safety Solutions and Pharmacovigilance Market - Industry Life Cycle |
3.4 China Drug Safety Solutions and Pharmacovigilance Market - Porter's Five Forces |
3.5 China Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 China Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume Share, By Functionality, 2021 & 2031F |
3.8 China Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume Share, By Delivery, 2021 & 2031F |
3.9 China Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.10 China Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Drug Safety Solutions and Pharmacovigilance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing focus on patient safety and regulatory compliance in China |
4.2.2 Growing pharmaceutical industry in China leading to higher demand for drug safety solutions |
4.2.3 Rising awareness about the importance of pharmacovigilance in ensuring drug safety and effectiveness |
4.3 Market Restraints |
4.3.1 Lack of standardized regulations and guidelines for pharmacovigilance in China |
4.3.2 Limited expertise and resources for implementing comprehensive drug safety solutions in the country |
5 China Drug Safety Solutions and Pharmacovigilance Market Trends |
6 China Drug Safety Solutions and Pharmacovigilance Market, By Types |
6.1 China Drug Safety Solutions and Pharmacovigilance Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 China Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Software, 2021- 2031F |
6.1.4 China Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Services, 2021- 2031F |
6.2 China Drug Safety Solutions and Pharmacovigilance Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 China Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Standard Form, 2021- 2031F |
6.2.3 China Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Customized Form, 2021- 2031F |
6.3 China Drug Safety Solutions and Pharmacovigilance Market, By Functionality |
6.3.1 Overview and Analysis |
6.3.2 China Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Adverse Event Reporting Software, 2021- 2031F |
6.3.3 China Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Drug Safety Audits Software, 2021- 2031F |
6.3.4 China Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Issue Tracking Software, 2021- 2031F |
6.4 China Drug Safety Solutions and Pharmacovigilance Market, By Delivery |
6.4.1 Overview and Analysis |
6.4.2 China Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By On-Premise Delivery Mode, 2021- 2031F |
6.4.3 China Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By On-Demand/Cloud-Based (SAAS) Delivery Mode, 2021- 2031F |
6.5 China Drug Safety Solutions and Pharmacovigilance Market, By End Users |
6.5.1 Overview and Analysis |
6.5.2 China Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Biotechnology and Pharmaceuticals, 2021- 2031F |
6.5.3 China Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Contract Research Organizations (CROS), 2021- 2031F |
6.5.4 China Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.5 China Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By KPOs/BPOs, 2021- 2031F |
6.5.6 China Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.6 China Drug Safety Solutions and Pharmacovigilance Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 China Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Direct Sales, 2021- 2031F |
6.6.3 China Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Retail Sales, 2021- 2031F |
7 China Drug Safety Solutions and Pharmacovigilance Market Import-Export Trade Statistics |
7.1 China Drug Safety Solutions and Pharmacovigilance Market Export to Major Countries |
7.2 China Drug Safety Solutions and Pharmacovigilance Market Imports from Major Countries |
8 China Drug Safety Solutions and Pharmacovigilance Market Key Performance Indicators |
8.1 Number of adverse drug reactions reported and monitored in China |
8.2 Compliance rate of pharmaceutical companies with pharmacovigilance regulations |
8.3 Adoption rate of advanced technology and tools for drug safety monitoring in the Chinese market |
9 China Drug Safety Solutions and Pharmacovigilance Market - Opportunity Assessment |
9.1 China Drug Safety Solutions and Pharmacovigilance Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Drug Safety Solutions and Pharmacovigilance Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 China Drug Safety Solutions and Pharmacovigilance Market Opportunity Assessment, By Functionality, 2021 & 2031F |
9.4 China Drug Safety Solutions and Pharmacovigilance Market Opportunity Assessment, By Delivery, 2021 & 2031F |
9.5 China Drug Safety Solutions and Pharmacovigilance Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.6 China Drug Safety Solutions and Pharmacovigilance Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Drug Safety Solutions and Pharmacovigilance Market - Competitive Landscape |
10.1 China Drug Safety Solutions and Pharmacovigilance Market Revenue Share, By Companies, 2024 |
10.2 China Drug Safety Solutions and Pharmacovigilance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here